Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC674120446;20447;20448 chr2:178727144;178727143;178727142chr2:179591871;179591870;179591869
N2AB642419495;19496;19497 chr2:178727144;178727143;178727142chr2:179591871;179591870;179591869
N2A549716714;16715;16716 chr2:178727144;178727143;178727142chr2:179591871;179591870;179591869
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Ig-51
  • Domain position: 75
  • Structural Position: 157
  • Q(SASA): 0.361
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/G rs1380825036 -1.96 0.999 N 0.718 0.341 0.589461000006 gnomAD-2.1.1 3.19E-05 None None None None N None 1.14811E-04 0 None 0 0 None 0 None 0 0 0
E/G rs1380825036 -1.96 0.999 N 0.718 0.341 0.589461000006 gnomAD-3.1.2 6.57E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
E/G rs1380825036 -1.96 0.999 N 0.718 0.341 0.589461000006 gnomAD-4.0.0 6.5735E-06 None None None None N None 2.41243E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.4094 ambiguous 0.4002 ambiguous -1.1 Destabilizing 0.975 D 0.628 neutral N 0.496163716 None None N
E/C 0.9707 likely_pathogenic 0.9647 pathogenic -0.602 Destabilizing 1.0 D 0.766 deleterious None None None None N
E/D 0.455 ambiguous 0.4399 ambiguous -1.391 Destabilizing 0.912 D 0.557 neutral N 0.506140896 None None N
E/F 0.9092 likely_pathogenic 0.9029 pathogenic -0.739 Destabilizing 0.999 D 0.791 deleterious None None None None N
E/G 0.6192 likely_pathogenic 0.6074 pathogenic -1.49 Destabilizing 0.999 D 0.718 prob.delet. N 0.506647875 None None N
E/H 0.6768 likely_pathogenic 0.6703 pathogenic -1.0 Destabilizing 1.0 D 0.626 neutral None None None None N
E/I 0.4916 ambiguous 0.4814 ambiguous -0.017 Destabilizing 0.988 D 0.744 deleterious None None None None N
E/K 0.1978 likely_benign 0.214 benign -0.781 Destabilizing 0.496 N 0.418 neutral N 0.498058749 None None N
E/L 0.6387 likely_pathogenic 0.6322 pathogenic -0.017 Destabilizing 0.958 D 0.712 prob.delet. None None None None N
E/M 0.6176 likely_pathogenic 0.6164 pathogenic 0.568 Stabilizing 0.995 D 0.763 deleterious None None None None N
E/N 0.6235 likely_pathogenic 0.6173 pathogenic -1.214 Destabilizing 0.993 D 0.591 neutral None None None None N
E/P 0.9966 likely_pathogenic 0.9963 pathogenic -0.358 Destabilizing 0.993 D 0.736 prob.delet. None None None None N
E/Q 0.1987 likely_benign 0.2031 benign -1.063 Destabilizing 0.995 D 0.594 neutral N 0.498405466 None None N
E/R 0.3932 ambiguous 0.3978 ambiguous -0.615 Destabilizing 0.994 D 0.595 neutral None None None None N
E/S 0.4874 ambiguous 0.4762 ambiguous -1.662 Destabilizing 0.981 D 0.575 neutral None None None None N
E/T 0.4445 ambiguous 0.426 ambiguous -1.316 Destabilizing 0.986 D 0.662 neutral None None None None N
E/V 0.3224 likely_benign 0.3049 benign -0.358 Destabilizing 0.431 N 0.567 neutral N 0.488689904 None None N
E/W 0.9764 likely_pathogenic 0.9753 pathogenic -0.557 Destabilizing 1.0 D 0.712 prob.delet. None None None None N
E/Y 0.8657 likely_pathogenic 0.8562 pathogenic -0.465 Destabilizing 1.0 D 0.781 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.